Net profit of Torrent Pharmaceuticals rose 10.91% to ₹ 498.00 crore in the quarter ended March 2025 as against ₹ 449.00 crore during the previous quarter ended March 2024. Sales rose 7.94% to ₹ 2909.00 crore in the quarter ended March 2025 as against ₹ 2695.00 crore during the previous quarter ended March 2024.
For the full year,net profit rose 15.40% to ₹ 1911.00 crore in the year ended March 2025 as against ₹ 1656.00 crore during the previous year ended March 2024. Sales rose 7.15% to ₹ 11317.00 crore in the year ended March 2025 as against ₹ 10562.00 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 2909.00 | 2695.00 | 8 | 11317.00 | 10562.00 | 7 |
| OPM % | 33.14 | 32.76 | - | 32.88 | 31.89 | - |
| PBDT | 890.00 | 834.00 | 7 | 3492.00 | 3072.00 | 14 |
| PBT | 689.00 | 631.00 | 9 | 2697.00 | 2264.00 | 19 |
| NP | 498.00 | 449.00 | 11 | 1911.00 | 1656.00 | 15 |